3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Leukemia
5
Myelodysplastic Syndromes
4
Lymphoma
3
Leukemia, Biphenotypic, Acute
3
Graft vs Host Disease
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myasthenia Gravis
2
Leukemia, Myeloid, Acute
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hodgkin Disease
2
Anemia, Refractory, with Excess of Blasts
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, B-Cell
1
Hepatitis
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Congenital Abnormalities
1
Colitis
1
Bronchiolitis Obliterans Syndrome
1
Anemia, Refractory
1
Interventions
vedolizumab
1
Photopheresis
1
Mycophenolic Acid
1
Methylprednisolone
1
Methoxsalen
1
Infliximab
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Colitis
×
Mycophenolic Acid
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled